Kipuwex

Kipuwex

Wireless, continuous care patient monitoring device that measures nine different physiological parameters.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*

N/A

Growth Equity VC
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR20182019202020222023
Revenues00000000000000000000
EBITDA00000000000000000000
Profit00000000000000000000
EV00000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x
R&D budget00000000000000000000

Source: Company filings or news article, Dealroom estimates

Notes (0)
More about Kipuwex
Made with AI
Edit

Kipuwex, a Finnish health-tech company, operates in the digital health and Internet of Medical Things (IoMT) sectors. The company was established in 2017 by Marko Höynälä, a serial entrepreneur with over 25 years of experience in telecommunications at companies like Nokia and Broadcom. His background in hardware innovation and a personal passion for accessible healthcare led him to create Kipuwex after winning a local hospital district's innovation competition. The competition sought a solution for objectively measuring pain in children, which became a foundational goal for the company.

The company develops and provides a compact, wireless remote monitoring device that attaches to a patient's chest. This IoMT device is designed to continuously measure up to 12 clinically relevant physiological parameters, which are then accessible to healthcare professionals via a mobile application. Kipuwex's core mission is to provide these health insights affordably, targeting not only established healthcare markets but also developing countries where monitoring devices are often scarce. The business model appears to be centered on selling these devices to healthcare providers, such as hospitals and clinics, and potentially to home users in the future. The company is also exploring veterinary applications for its technology.

A significant feature of the Kipuwex solution is its algorithm that translates physiological data into an objective measurement of pain, addressing a critical need for non-communicative patients like infants or the critically ill. The company has achieved a major regulatory milestone by securing NMPA approval in China, allowing the device to be distributed under the brand name Isogang through a partnership with Bepsun Eurotech Solution Oy. Kipuwex is also actively pursuing market entry into the United States and India, engaging with distributors and health ministries. The company is venture capital-backed, having gone through early-stage VC funding and an accelerator program.

Keywords: remote patient monitoring, medical device, IoMT, vital signs, digital health, health-tech, pain management, telehealth, diagnostics, wearable sensors

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo